- Conditions
- Tracheobronchomalacia
- Interventions
- Bioresorbable Tracheobronchial Splint
- Device
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 1 Week to 3 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2034
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
Source: ClinicalTrials.gov public record
Updated Jan 20, 2026 · Synced May 21, 2026, 8:08 PM EDT